Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease

American Journal of Hematology

Volumn 86, Issue 8, 2011, Pages 712-714

  Milner, Laurie A ^a   Becker, Michael W ^a   Bernstein, Steven H ^a   Bruckner, Lauren ^a   Friedberg, Jonathan W ^a   Holland, George A ^a   Ifthikharuddin, J J ^a   Liesveld, Jane L ^a   Mathes, Edward J ^a   Menchel, Heather L ^a   Mullen, Craig A ^a   Sasson, Talia ^a   Phillips II, Gordon L ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; ETANERCEPT; INFLIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; CELIAC ARTERY; CHILD; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL TRACT; HEPATIC ARTERY; HUMAN; INFERIOR MESENTERIC ARTERY; LETTER; LIVER; MALE; PRIORITY JOURNAL; SCHOOL CHILD; STEROID REFRACTORY OR DEPENDENT ACUTE GRAFT VERSUS HOST DISEASE; SUPERIOR MESENTERIC ARTERY; TREATMENT RESPONSE;

ADULT; CHILD; DRUG RESISTANCE; FEMALE; GASTROINTESTINAL TRACT; GLUCOCORTICOIDS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INJECTIONS, INTRA-ARTERIAL; LIVER; MALE; MEDICAL RECORDS; METHYLPREDNISOLONE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 79960373953     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22075     Document Type: Letter

References (19)

1. Paczesny S, Choi SW, Ferrara JLM. Acute graft-versus-host disease: New treatment strategies. Curr Opin Hematol 2009; 16: 427-446.
2. Deeg HJ. How I treat refractory acute GVHD. Blood 2007; 109: 4119-4126.
3. Alousi AM, Weisdorf DJ, Logan BR, et al. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: A randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood 2009; 114: 511-517.
4. Berger M, Biasin E, Saglio F, Fagioli F. Innovative approaches to treat steroid-resistant or steroid refractory GVHD. Bone Marrow Transplant 2008;(42 Suppl 2): S101-S105.
5. Sato T, Sakamaki S, Nagaoka Y, et al. Intra-mesenteric artery steroid administration relieved severe refractory gastro-intestinal graft-vs-host disease in an allogeneic bone marrow transplantation patient. Am J Hematol 1997; 56: 277-280.
6. Shapira MY, Bloom AI, Or R, et al. Intra-arterial catheter directed therapy for severe graft-vs-host disease. Br J Haematol 2002; 119: 760-764.
7. Nakai K, Tajima K, Tanigawa N, et al. Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography. Bone Marrow Transplant 2004; 33: 1231-1233.
8. Tfayli A, Selby G, Maqbool F, et al. Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-vs host disease. Am J Hematol 2006; 81: 959-962.
9. Shapira MY, Bloom AI, Or R, et al. Intra-arterial catheter directed immunosuppressive therapy for steroid resistant or dependent graft vs host disease (GVHD). Biol Blood Marrow Transplant 2002; 14(Suppl 1): S2 (abstract 379).
10. Weintraub JL, Belanger AR, Sung CC, et al. Intra-arterial methylprednisolone infusion in treatment-resistant graft-versus-host disease. Cardiovasc Intervent Radiol 2010; 33: 509-512.
11. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-1561.
12. Wolff D, Steiner B, Hildebrandt G, et al. Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease. Curr Pharm Des 2009; 15: 1974-1997.
13. Hill GR, Ferrara J. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754-2759.
14. Rogler G, Meinel A, Lingauer A, et al. Glucocorticoid receptors are down-regulated in inflamed colon mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease. Eur J Clin Invest 1999; 29: 278-279.
15. Raddatz D, Middel P, Bockem M, et al. Glucocorticoid receptor expression in inflammatory bowel disease: Evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis. Aliment Pharmacol Ther 2004; 19: 47-61.
16. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009; 373: 1905-1917.
17. Bloom AI, Shapira MY, Or R, et al. Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: An open-label uncontrolled trial. Clin Ther 2004; 26: 407-414.
18. McDonald GB. Oral beclomethasone dipropionate: A topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation. Expert Opin Investig Drugs 2007; 16: 1709-1724.
19. Martin PJ. Study design and endpoints in graft-versus-host disease. Best Pract Res Clin Haematol 2008; 21: 357-372.